The IPMOZYL brand, founded in 2007 (Sweden), from 585 sister brands and 17478 competing brands. IPMOZYL is owned by ASTRAZENECA, listed on the stock exchange of London Its International Securities Identification Number (ISIN) is GB0009895292. IPMOZYL is part of the Drug Manufacturers activity sector.